A detailed history of Commonwealth Equity Services, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 24,421 shares of NTLA stock, worth $295,494. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,421
Previous 27,537 11.32%
Holding current value
$295,494
Previous $616,000 18.51%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$19.72 - $27.36 $61,447 - $85,253
-3,116 Reduced 11.32%
24,421 $502,000
Q2 2024

Jul 31, 2024

SELL
$20.02 - $27.22 $141,261 - $192,064
-7,056 Reduced 20.4%
27,537 $616,000
Q1 2024

Apr 29, 2024

BUY
$23.82 - $32.8 $48,449 - $66,715
2,034 Added 6.25%
34,593 $952,000
Q4 2023

Feb 06, 2024

BUY
$23.16 - $32.34 $49,655 - $69,336
2,144 Added 7.05%
32,559 $993,000
Q3 2023

Oct 23, 2023

BUY
$31.62 - $45.78 $60,394 - $87,439
1,910 Added 6.7%
30,415 $962,000
Q2 2023

Aug 10, 2023

BUY
$34.58 - $46.03 $6,777 - $9,021
196 Added 0.69%
28,505 $1.16 Million
Q1 2023

May 11, 2023

BUY
$33.3 - $44.82 $37,395 - $50,332
1,123 Added 4.13%
28,309 $1.06 Million
Q4 2022

Feb 07, 2023

BUY
$33.21 - $62.69 $286,070 - $540,011
8,614 Added 46.38%
27,186 $948,000
Q3 2022

Nov 14, 2022

SELL
$53.92 - $71.7 $131,187 - $174,446
-2,433 Reduced 11.58%
18,572 $1.04 Million
Q2 2022

Jul 19, 2022

SELL
$38.49 - $76.21 $187,446 - $371,142
-4,870 Reduced 18.82%
21,005 $1.09 Million
Q1 2022

May 04, 2022

SELL
$58.27 - $118.99 $41,022 - $83,768
-704 Reduced 2.65%
25,875 $1.88 Million
Q4 2021

Jan 31, 2022

BUY
$100.76 - $138.36 $18,338 - $25,181
182 Added 0.69%
26,579 $3.14 Million
Q3 2021

Oct 29, 2021

SELL
$132.37 - $176.78 $94,379 - $126,044
-713 Reduced 2.63%
26,397 $3.54 Million
Q2 2021

Aug 11, 2021

BUY
$60.88 - $161.91 $143,189 - $380,812
2,352 Added 9.5%
27,110 $4.39 Million
Q1 2021

May 04, 2021

BUY
$46.59 - $83.68 $9,271 - $16,652
199 Added 0.81%
24,758 $1.99 Million
Q4 2020

Feb 11, 2021

BUY
$18.83 - $63.53 $7,343 - $24,776
390 Added 1.61%
24,559 $1.34 Million
Q3 2020

Nov 05, 2020

BUY
$17.47 - $24.93 $4,280 - $6,107
245 Added 1.02%
24,169 $480,000
Q2 2020

Aug 12, 2020

SELL
$11.14 - $22.87 $60,311 - $123,818
-5,414 Reduced 18.45%
23,924 $502,000
Q1 2020

May 11, 2020

BUY
$9.44 - $15.58 $69,251 - $114,294
7,336 Added 33.34%
29,338 $358,000
Q4 2019

Feb 05, 2020

SELL
$10.43 - $17.67 $13,798 - $23,377
-1,323 Reduced 5.67%
22,002 $322,000
Q3 2019

Oct 30, 2019

BUY
$13.07 - $18.51 $9,619 - $13,623
736 Added 3.26%
23,325 $311,000
Q2 2019

Jul 19, 2019

BUY
$13.88 - $18.41 $117,147 - $155,380
8,440 Added 59.65%
22,589 $369,000
Q1 2019

May 13, 2019

BUY
$12.79 - $17.62 $42,015 - $57,881
3,285 Added 30.24%
14,149 $241,000
Q4 2018

Feb 11, 2019

BUY
$11.39 - $27.13 $21,219 - $50,543
1,863 Added 20.7%
10,864 $148,000
Q3 2018

Nov 06, 2018

SELL
$25.78 - $32.6 $10,672 - $13,496
-414 Reduced 4.4%
9,001 $257,000
Q2 2018

Jul 31, 2018

SELL
$20.02 - $30.79 $5,365 - $8,251
-268 Reduced 2.77%
9,415 $258,000
Q1 2018

May 14, 2018

BUY
$19.43 - $34.95 $188,140 - $338,420
9,683 New
9,683 $204,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $920M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.